Ignite Creation Date:
2025-12-25 @ 2:44 AM
Ignite Modification Date:
2026-05-16 @ 2:53 AM
Study NCT ID:
NCT00668733
Status:
COMPLETED
Last Update Posted:
2010-07-20
First Post:
2008-04-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Follow-up Study to Evaluate Sustained Clearance Rates of Actinic Keratoses up to One Year
Sponsor:
Graceway Pharmaceuticals, LLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
GW01-0803
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Sharon Levy, MD / Vice President, Product Development
Old Organization:
Graceway Pharmaceuticals, LLC